Adverse Events Module
For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
Adverse Events Module
Ignite Creation Date:
2025-12-24 @ 3:18 PM
Ignite Modification Date:
2025-12-25 @ 1:38 PM
NCT ID:
NCT00030992
Description:
None
Frequency Threshold:
0
Time Frame:
10 years
Study:
NCT00030992
Study Brief:
BMS 247550 to Treat Kidney Cancer
Event Groups(If Any):
Event Groups
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| BMS-247550 | One hour infusion on five successive days (daily x 5) every three weeks. Starting dose of 6 mg/m\^2/day for a total per cycle dose of 30 mg/m\^2 | None | None | 40 | 102 | 99 | 102 | View |
Serious Events(If Any):
Serious Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Acute kidney injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Alkaline phosphatase | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Allergic reaction/hypersensitivity (including drug fever) | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv2.0 | View |
| Cardiac left ventricular function | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Cardiac troponin T (cTnT) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Cardiac-ischemia/infarction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Catheter-related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Circulatory or cardiac-Other (hypertension) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| CNS cerebrovascular ischemia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| CPK (creatine phosphokinase) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Creatinine | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Diarrhea (without colostomy) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Dysphagia, esophagitis, odynophagia (painful swallowing) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Dyspnea (shortness of breath) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Edema | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Fatigue (lethargy, malaise, asthenia) | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Hematuria (in the absence of vaginal bleeding) | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Hemoglobin (hgb) | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Hemoglobin increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Hemoptysis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Hemorrhage/bleeding associated with surgery | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypertriglyceridemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hyperuricemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypomagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Hypoxia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Infection with neutropenia | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Infection without neutropenia | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Infection, Other (other than fever with neutropenia) | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Joint, muscle, or bone (osseous)-Other (fracture) | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| Melena/GI bleeding | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Neurologic-Other (autonomic neuropathy) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Neuropathic pain | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Neuropathy-motor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Neutrophils/granulocytes (ANC/AGC) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Pain-neuropathic | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Pleural effusion (non-malignant) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Pneumothorax | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Pericardial effusion/pericarditis | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Pulmonary-Other: malignant pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Seizure(s) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| SGOT (AST) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| SGPT (ALT) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Stomatitis/pharyngitis (oral/pharyngeal mucositis) for BMT | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Supraventricular arrhythmias (SVT/atrial fibrillation/flutter) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Thrombosis/embolism | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Vasovagal reaction | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Voice changes/stridor/larynx | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Weight loss | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Adult respiratory distress syndrome (ARDS) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
Other Events(If Any):
Other Events
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Neuropathy-motor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Alopecia | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Abdominal pain | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Abdominal pain or cramping | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Acidosis | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Activated partial thromboplastin time prolonged | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Alanine aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Alkaline phosphokinase | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Alkaline phosphokinase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Allergic reaction/hypersensitivity (including drug fever) | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv2.0 | View |
| Allergic rhinitis | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv2.0 | View |
| Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | SYSTEMATIC_ASSESSMENT | Immune system disorders | CTCv2.0 | View |
| Allergy-Other (rhinitis) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Amylase | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Anemia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Arthralgia | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| Arthralgia (joint pain) | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| Aspartate aminotransferase increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Bilirubin | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | CTCv2.0 | View |
| Blood and lymphatic system disorders-Other, specify (bruising) | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Blood bilirubin increased | SYSTEMATIC_ASSESSMENT | Hepatobiliary disorders | CTCv2.0 | View |
| Blurred vision | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Bone pain | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| Bruising (in absence of grade 3 or 4 thrombocytopenia) | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv2.0 | View |
| Cardiac troponin I increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Cardiac-ischemia/infarction | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Catheter-related infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Chest pain (non-cardiac and non-pleuritic) | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Chills | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Cholesterol high | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Circulatory or cardiac-Other (edema) | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Confusion | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv2.0 | View |
| Conjunctivitis | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| CPK (creatine phosphokinase) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| CPK increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Creatinine | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Creatinine increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Depressed level of consciousness | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv2.0 | View |
| Dermatitis, focal | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Diarrhea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Diarrhea (without colostomy) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Dizziness/lightheadedness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Dry eye | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Dry skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Dysgeusia | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Dyspepsia/heartburn | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Dysuria (painful urination) | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Ear and labyrinth disorders-Other, specify (tinnitus) | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv2.0 | View |
| Edema | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Epistaxis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Erythema multiforme | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| External auditory canal | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv2.0 | View |
| Extrapyramidal/involuntary movement/restlessness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Eye disorders-Other, specify (blepharitis) | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Fatigue (lethargy, malaise, asthenia) | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Febrile neutropenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Fever (in absence of neutropenia, where neutropenia is defined as AGC<1.0x109/L) | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Flushing | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Gastritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Generalized muscle weakness | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| GI-Other (bloating) | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Hematuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Hematuria (in the absence of vaginal bleeding) | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Hemoglobin (hgb) | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Hemoglobin increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Hemoptysis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Hemorrhage/bleeding associated with surgery | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Hemorrhage/bleeding without grade 3 or 4 thrombocytopenia | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Hot flashes/flashes | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Hypercalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypercholesterolemia | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Hyperglycemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hyperkalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypermagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypernatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypertriglyceridemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hyperuricemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypocalcemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypokalemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypomagnesemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hyponatremia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypophosphatemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | CTCv2.0 | View |
| Hypotension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Incontinence | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Infection without neutropenia | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Infection, Other (skin) | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Infections and infestations-Other, specify (skin) | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| INR increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv2.0 | View |
| Joint, muscle, or bone (osseous)-Other (myalgia) | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| Leukocytes (total WBC) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Leukoencephalopathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Lymphocyte count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Lymphocyte count increased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Memory loss | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Middle ear/hearing | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | CTCv2.0 | View |
| Mood alteration-anxiety agitation | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv2.0 | View |
| Mood alteration-depression | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv2.0 | View |
| Mood alteration-euphoria | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | CTCv2.0 | View |
| Muscle weakness (not due to neuropathy) | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| Myalgia (muscle ache) | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | CTCv2.0 | View |
| Nail changes | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Nail discoloration | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Nail loss | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Nervous system disorders-Other, specify (vasovagal) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Neurologic-Other (dizziness) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Neuropathic pain | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Neuropathy-sensory | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Neutrophil count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Neutrophils/granulocytes (ANC/AGC) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Ocular-Other (blurred vision) | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Pain-Other (dysethesia) | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Palpitation | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Partial thromboplastin time (PTT) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Peripheral sensory neuropathy | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Petechiae/purpura (hemorrhage/bleeding into skin or mucosa) | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Phlebitis (superficial) | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Platelet count decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Platelets | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Pleural effusion | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Pleuritic pain | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Postnasal drip | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Postoperative hemorrhage | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv2.0 | View |
| Pericardial effusion/pericarditis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Prothrombin time (PT) | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Pruritis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Rash/desquamation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Renal/GU-Other (urgency) | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Rigors, chills | SYSTEMATIC_ASSESSMENT | General disorders | CTCv2.0 | View |
| Salivary gland changes | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Sense of smell | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| SGOT (AST) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| SGPT (ALT) | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Sinus tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | CTCv2.0 | View |
| Skin-Other (dry skin) | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Stomatitis/pharyngitis (oral/pharyngeal mucositis) | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Stomatitis/pharyngitis (oral/pharyngeal mucositis) for BMT | SYSTEMATIC_ASSESSMENT | Infections and infestations | CTCv2.0 | View |
| Sweating | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | CTCv2.0 | View |
| Syncope | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Taste disturbance (dysgeusia) | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Tearing (watery eyes) | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Thromboembolic event | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Thrombosis/embolism | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |
| Transfusion:pRBCs | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | CTCv2.0 | View |
| Tremor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | CTCv2.0 | View |
| Tumor pain | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CTCv2.0 | View |
| Tumor pain (onset or exacerbation of tumor pain due to treatment) | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | CTCv2.0 | View |
| Ureteral obstruction | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Urinary frequency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Urinary frequency/urgency | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Urinary retention | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | CTCv2.0 | View |
| Vaginal bleeding | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv2.0 | View |
| Vaginal dryness | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | CTCv2.0 | View |
| Vision-blurred vision | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Vision-flashing lights/floaters | SYSTEMATIC_ASSESSMENT | Eye disorders | CTCv2.0 | View |
| Voice changes/stridor/larynx | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | CTCv2.0 | View |
| Weight loss | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| White blood cell decreased | SYSTEMATIC_ASSESSMENT | Investigations | CTCv2.0 | View |
| Wound dehiscence | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv2.0 | View |
| Wound-infectious | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv2.0 | View |
| Wound-non-infectious | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | CTCv2.0 | View |
| Dyspnea (shortness of breath) | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | CTCv2.0 | View |
| Hypertension | SYSTEMATIC_ASSESSMENT | Vascular disorders | CTCv2.0 | View |